Anthem Stock Forecast for 2022 - 2025 - 2030
Updated on 09/27/2022
Anthem Stock Forecast and Price Target
Anthem's stock price reaches the average target of $556.00 by 2023 as expected recently by eight notable experts, there would be a potential upside of approximately 24.07% from the last closing price in September, 2022. This possible increase is based on a high estimate of $610.00 and a low estimate of $335.00. If you are not interested in ANTM stock, you may be interested in its competitors.
24.07% Upside
Anthem Fair Value Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's Price has grown, increasing from $264.41 to $432.31 – a growth of 63.50%. The next year looks promising for Anthem, with analysts predicting Fair Value of $476.40 – an increase of 10.20%. Over the next nine years, experts anticipate that Anthem's Fair Value will grow at a rate of 145.77%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRK.A Stock Forecast | Berkshire Hathaway | Outperform |
14
|
$399.13k | Buy/Sell | $543.36k | 34.04% |
| UNH Stock Forecast | UnitedHealth Group | Outperform |
16
|
$508.36 | Buy/Sell | $573.63 | 15.57% |
| WMT Stock Forecast | Walmart | Outperform |
15
|
$131.31 | Buy/Sell | $168.96 | 17.28% |
| CI Stock Forecast | Cigna | Outperform |
15
|
$276.80 | Buy/Sell | $295.91 | 14.88% |
| ALV Stock Forecast | Allianz | Outperform |
13
|
165.74€ | Buy/Sell | 249.88€ | 34.25% |
Anthem Revenue Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's Revenue has grown, increasing from $92.09B to $138.64B – a growth of 50.55%. The next year looks promising for Anthem, with analysts predicting Revenue of $153.37B – an increase of 10.63%. Over the next nine years, experts anticipate that Anthem's Revenue will grow at a rate of 102.23%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HUM Stock Forecast | Humana | Outperform |
15
|
$482.63 | Buy/Sell | $504.43 | 13.86% |
| CS Stock Forecast | AXA | Buy |
18
|
23.52€ | Buy/Sell | 26.51€ | 31.80% |
| CNC Stock Forecast | Centene | Outperform |
12
|
$77.71 | Buy/Sell | $95.95 | 32.54% |
.jpg)
Anthem Dividend per Share Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's Dividend per Share has grown by 50.67%, from $3.00 to $4.52. For the next year, analysts are expecting Dividend per Share to reach $4.96 – an increase of 9.73%. Over the next nine years, experts predict that Dividend per Share will grow by 154.20%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AIG Stock Forecast | American International Group | Outperform |
13
|
$48.41 | Buy/Sell | $67.50 | 38.40% |
| AFL Stock Forecast | Aflac | Hold |
13
|
$56.83 | Buy/Sell | $60.77 | 9.10% |
| MUV2 Stock Forecast | Münchener Rückversicherungs-... | Outperform |
16
|
245.30€ | Buy/Sell | 276.04€ | 14.35% |
Anthem Free Cash Flow Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's Free Cash Flow has grown by 177.85%, rising from $2.62B to $7.28B. In the following year, the 3 analysts surveyed believe that Anthem's Free Cash Flow will decrease by 15.21%, reaching $6.17B. Over the next nine years, experts predict that Anthem's Free Cash Flow will grow at a rate of 49.03%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| G Stock Forecast | Assicurazioni Generali S.p.A. | Outperform |
18
|
14.57€ | Buy/Sell | 17.63€ | 37.27% |
| MOH Stock Forecast | Molina Healthcare | Hold |
16
|
$326.82 | Buy/Sell | $328.38 | 9.39% |
| CAH Stock Forecast | Cardinal Health | Hold |
13
|
$65.77 | Buy/Sell | $58.69 | 3.39% |
Anthem Net Income Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's Net Income has grown from $3.75B to $6.10B – a 62.77% increase. Next year, analysts are expecting Net Income to reach $6.94B – an increase of 13.76%. Over the next nine years, the forecast is for Net Income to grow by 95.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AV. Stock Forecast | Aviva | Outperform |
16
|
£4.15 | Buy/Sell | £4.70 | 20.48% |
| DVA Stock Forecast | DaVita | Outperform |
16
|
$84.40 | Buy/Sell | $124.50 | 14.93% |
| UHS Stock Forecast | Universal Health Services | Hold |
11
|
$89.89 | Buy/Sell | $147.80 | 26.82% |
Anthem EBITDA Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's EBITDA has grown by 53.61%, rising from $6.36B to $9.77B. For next year, analysts predict EBITDA of $11.16B, which would mean an increase of 14.23%. Over the next nine years, experts predict that Anthem's EBITDA will grow at a rate of 81.55%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INOV Stock Forecast | Inovalon Holdings | - |
14
|
$41.06 | Buy/Sell | $41.00 | 18.80% |
| 7181 Stock Forecast | Japan Post Insurance | Outperform |
16
|
¥2.15k | Buy/Sell | ¥0.00 | 4.90% |
| THC Stock Forecast | Tenet Healthcare | Buy |
15
|
$50.67 | Buy/Sell | $82.53 | 79.59% |
Anthem EBIT Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's EBIT has grown, rising from $5.82B to $8.96B – a growth of 53.95%. In the next year, analysts believe that EBIT will reach $9.93B – an increase of 10.83%. For the next nine years, the forecast is for EBIT to grow by 110.26%.
Anthem EPS Price Prediction Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's EPS has grown, increasing from $15.89 to $25.98 – a growth of 63.50%. The next year looks promising for Anthem, with analysts predicting EPS of $28.63 – an increase of 10.20%. Over the next nine years, experts anticipate that Anthem's EPS will grow at a rate of 145.77%.
.jpg)